Report Detail

Chemical & Material Global Doxorubicin Hydrochloride API Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

  • RnM4562802
  • |
  • 21 October, 2023
  • |
  • Global
  • |
  • 102 Pages
  • |
  • GIR (Global Info Research)
  • |
  • Chemical & Material

According to our (Global Info Research) latest study, the global Doxorubicin Hydrochloride API market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period.
The Global Info Research report includes an overview of the development of the Doxorubicin Hydrochloride API industry chain, the market status of Injection (Purity≥98%, Purity<98%
Market segment by Application
Injection
Freeze-dried Powder Injection
Liposomal Injection
Major players covered
Intas Pharmaceuticals Ltd
Olon Spa
Sterling Biotech Ltd
Synbias Pharma Ag
Teva Pharmaceutical Industries Ltd
Meiji Seika Pharma Co Ltd
Microbiopharm Japan Co Ltd
Pharmacia And Upjohn Co
Boryung Pharmaceutical
Transo-Pharm Handels Gmbh
Dzd Heze Pharmaceutical Co Ltd
Zhejiang Hisun Pharmaceutical
Guangdong Lingnan Pharmaceutical
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Doxorubicin Hydrochloride API product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Doxorubicin Hydrochloride API, with price, sales, revenue and global market share of Doxorubicin Hydrochloride API from 2018 to 2023.
Chapter 3, the Doxorubicin Hydrochloride API competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Doxorubicin Hydrochloride API breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Doxorubicin Hydrochloride API market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Doxorubicin Hydrochloride API.
Chapter 14 and 15, to describe Doxorubicin Hydrochloride API sales channel, distributors, customers, research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope of Doxorubicin Hydrochloride API
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Doxorubicin Hydrochloride API Consumption Value by Type: 2018 Versus 2022 Versus 2029
    • 1.3.2 Purity≥98%
    • 1.3.3 Purity<98%
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Doxorubicin Hydrochloride API Consumption Value by Application: 2018 Versus 2022 Versus 2029
    • 1.4.2 Injection
    • 1.4.3 Freeze-dried Powder Injection
    • 1.4.4 Liposomal Injection
  • 1.5 Global Doxorubicin Hydrochloride API Market Size & Forecast
    • 1.5.1 Global Doxorubicin Hydrochloride API Consumption Value (2018 & 2022 & 2029)
    • 1.5.2 Global Doxorubicin Hydrochloride API Sales Quantity (2018-2029)
    • 1.5.3 Global Doxorubicin Hydrochloride API Average Price (2018-2029)

2 Manufacturers Profiles

  • 2.1 Intas Pharmaceuticals Ltd
    • 2.1.1 Intas Pharmaceuticals Ltd Details
    • 2.1.2 Intas Pharmaceuticals Ltd Major Business
    • 2.1.3 Intas Pharmaceuticals Ltd Doxorubicin Hydrochloride API Product and Services
    • 2.1.4 Intas Pharmaceuticals Ltd Doxorubicin Hydrochloride API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.1.5 Intas Pharmaceuticals Ltd Recent Developments/Updates
  • 2.2 Olon Spa
    • 2.2.1 Olon Spa Details
    • 2.2.2 Olon Spa Major Business
    • 2.2.3 Olon Spa Doxorubicin Hydrochloride API Product and Services
    • 2.2.4 Olon Spa Doxorubicin Hydrochloride API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.2.5 Olon Spa Recent Developments/Updates
  • 2.3 Sterling Biotech Ltd
    • 2.3.1 Sterling Biotech Ltd Details
    • 2.3.2 Sterling Biotech Ltd Major Business
    • 2.3.3 Sterling Biotech Ltd Doxorubicin Hydrochloride API Product and Services
    • 2.3.4 Sterling Biotech Ltd Doxorubicin Hydrochloride API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.3.5 Sterling Biotech Ltd Recent Developments/Updates
  • 2.4 Synbias Pharma Ag
    • 2.4.1 Synbias Pharma Ag Details
    • 2.4.2 Synbias Pharma Ag Major Business
    • 2.4.3 Synbias Pharma Ag Doxorubicin Hydrochloride API Product and Services
    • 2.4.4 Synbias Pharma Ag Doxorubicin Hydrochloride API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.4.5 Synbias Pharma Ag Recent Developments/Updates
  • 2.5 Teva Pharmaceutical Industries Ltd
    • 2.5.1 Teva Pharmaceutical Industries Ltd Details
    • 2.5.2 Teva Pharmaceutical Industries Ltd Major Business
    • 2.5.3 Teva Pharmaceutical Industries Ltd Doxorubicin Hydrochloride API Product and Services
    • 2.5.4 Teva Pharmaceutical Industries Ltd Doxorubicin Hydrochloride API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.5.5 Teva Pharmaceutical Industries Ltd Recent Developments/Updates
  • 2.6 Meiji Seika Pharma Co Ltd
    • 2.6.1 Meiji Seika Pharma Co Ltd Details
    • 2.6.2 Meiji Seika Pharma Co Ltd Major Business
    • 2.6.3 Meiji Seika Pharma Co Ltd Doxorubicin Hydrochloride API Product and Services
    • 2.6.4 Meiji Seika Pharma Co Ltd Doxorubicin Hydrochloride API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.6.5 Meiji Seika Pharma Co Ltd Recent Developments/Updates
  • 2.7 Microbiopharm Japan Co Ltd
    • 2.7.1 Microbiopharm Japan Co Ltd Details
    • 2.7.2 Microbiopharm Japan Co Ltd Major Business
    • 2.7.3 Microbiopharm Japan Co Ltd Doxorubicin Hydrochloride API Product and Services
    • 2.7.4 Microbiopharm Japan Co Ltd Doxorubicin Hydrochloride API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.7.5 Microbiopharm Japan Co Ltd Recent Developments/Updates
  • 2.8 Pharmacia And Upjohn Co
    • 2.8.1 Pharmacia And Upjohn Co Details
    • 2.8.2 Pharmacia And Upjohn Co Major Business
    • 2.8.3 Pharmacia And Upjohn Co Doxorubicin Hydrochloride API Product and Services
    • 2.8.4 Pharmacia And Upjohn Co Doxorubicin Hydrochloride API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.8.5 Pharmacia And Upjohn Co Recent Developments/Updates
  • 2.9 Boryung Pharmaceutical
    • 2.9.1 Boryung Pharmaceutical Details
    • 2.9.2 Boryung Pharmaceutical Major Business
    • 2.9.3 Boryung Pharmaceutical Doxorubicin Hydrochloride API Product and Services
    • 2.9.4 Boryung Pharmaceutical Doxorubicin Hydrochloride API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.9.5 Boryung Pharmaceutical Recent Developments/Updates
  • 2.10 Transo-Pharm Handels Gmbh
    • 2.10.1 Transo-Pharm Handels Gmbh Details
    • 2.10.2 Transo-Pharm Handels Gmbh Major Business
    • 2.10.3 Transo-Pharm Handels Gmbh Doxorubicin Hydrochloride API Product and Services
    • 2.10.4 Transo-Pharm Handels Gmbh Doxorubicin Hydrochloride API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.10.5 Transo-Pharm Handels Gmbh Recent Developments/Updates
  • 2.11 Dzd Heze Pharmaceutical Co Ltd
    • 2.11.1 Dzd Heze Pharmaceutical Co Ltd Details
    • 2.11.2 Dzd Heze Pharmaceutical Co Ltd Major Business
    • 2.11.3 Dzd Heze Pharmaceutical Co Ltd Doxorubicin Hydrochloride API Product and Services
    • 2.11.4 Dzd Heze Pharmaceutical Co Ltd Doxorubicin Hydrochloride API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.11.5 Dzd Heze Pharmaceutical Co Ltd Recent Developments/Updates
  • 2.12 Zhejiang Hisun Pharmaceutical
    • 2.12.1 Zhejiang Hisun Pharmaceutical Details
    • 2.12.2 Zhejiang Hisun Pharmaceutical Major Business
    • 2.12.3 Zhejiang Hisun Pharmaceutical Doxorubicin Hydrochloride API Product and Services
    • 2.12.4 Zhejiang Hisun Pharmaceutical Doxorubicin Hydrochloride API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.12.5 Zhejiang Hisun Pharmaceutical Recent Developments/Updates
  • 2.13 Guangdong Lingnan Pharmaceutical
    • 2.13.1 Guangdong Lingnan Pharmaceutical Details
    • 2.13.2 Guangdong Lingnan Pharmaceutical Major Business
    • 2.13.3 Guangdong Lingnan Pharmaceutical Doxorubicin Hydrochloride API Product and Services
    • 2.13.4 Guangdong Lingnan Pharmaceutical Doxorubicin Hydrochloride API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.13.5 Guangdong Lingnan Pharmaceutical Recent Developments/Updates

3 Competitive Environment: Doxorubicin Hydrochloride API by Manufacturer

  • 3.1 Global Doxorubicin Hydrochloride API Sales Quantity by Manufacturer (2018-2023)
  • 3.2 Global Doxorubicin Hydrochloride API Revenue by Manufacturer (2018-2023)
  • 3.3 Global Doxorubicin Hydrochloride API Average Price by Manufacturer (2018-2023)
  • 3.4 Market Share Analysis (2022)
    • 3.4.1 Producer Shipments of Doxorubicin Hydrochloride API by Manufacturer Revenue ($MM) and Market Share (%): 2022
    • 3.4.2 Top 3 Doxorubicin Hydrochloride API Manufacturer Market Share in 2022
    • 3.4.2 Top 6 Doxorubicin Hydrochloride API Manufacturer Market Share in 2022
  • 3.5 Doxorubicin Hydrochloride API Market: Overall Company Footprint Analysis
    • 3.5.1 Doxorubicin Hydrochloride API Market: Region Footprint
    • 3.5.2 Doxorubicin Hydrochloride API Market: Company Product Type Footprint
    • 3.5.3 Doxorubicin Hydrochloride API Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Doxorubicin Hydrochloride API Market Size by Region
    • 4.1.1 Global Doxorubicin Hydrochloride API Sales Quantity by Region (2018-2029)
    • 4.1.2 Global Doxorubicin Hydrochloride API Consumption Value by Region (2018-2029)
    • 4.1.3 Global Doxorubicin Hydrochloride API Average Price by Region (2018-2029)
  • 4.2 North America Doxorubicin Hydrochloride API Consumption Value (2018-2029)
  • 4.3 Europe Doxorubicin Hydrochloride API Consumption Value (2018-2029)
  • 4.4 Asia-Pacific Doxorubicin Hydrochloride API Consumption Value (2018-2029)
  • 4.5 South America Doxorubicin Hydrochloride API Consumption Value (2018-2029)
  • 4.6 Middle East and Africa Doxorubicin Hydrochloride API Consumption Value (2018-2029)

5 Market Segment by Type

  • 5.1 Global Doxorubicin Hydrochloride API Sales Quantity by Type (2018-2029)
  • 5.2 Global Doxorubicin Hydrochloride API Consumption Value by Type (2018-2029)
  • 5.3 Global Doxorubicin Hydrochloride API Average Price by Type (2018-2029)

6 Market Segment by Application

  • 6.1 Global Doxorubicin Hydrochloride API Sales Quantity by Application (2018-2029)
  • 6.2 Global Doxorubicin Hydrochloride API Consumption Value by Application (2018-2029)
  • 6.3 Global Doxorubicin Hydrochloride API Average Price by Application (2018-2029)

7 North America

  • 7.1 North America Doxorubicin Hydrochloride API Sales Quantity by Type (2018-2029)
  • 7.2 North America Doxorubicin Hydrochloride API Sales Quantity by Application (2018-2029)
  • 7.3 North America Doxorubicin Hydrochloride API Market Size by Country
    • 7.3.1 North America Doxorubicin Hydrochloride API Sales Quantity by Country (2018-2029)
    • 7.3.2 North America Doxorubicin Hydrochloride API Consumption Value by Country (2018-2029)
    • 7.3.3 United States Market Size and Forecast (2018-2029)
    • 7.3.4 Canada Market Size and Forecast (2018-2029)
    • 7.3.5 Mexico Market Size and Forecast (2018-2029)

8 Europe

  • 8.1 Europe Doxorubicin Hydrochloride API Sales Quantity by Type (2018-2029)
  • 8.2 Europe Doxorubicin Hydrochloride API Sales Quantity by Application (2018-2029)
  • 8.3 Europe Doxorubicin Hydrochloride API Market Size by Country
    • 8.3.1 Europe Doxorubicin Hydrochloride API Sales Quantity by Country (2018-2029)
    • 8.3.2 Europe Doxorubicin Hydrochloride API Consumption Value by Country (2018-2029)
    • 8.3.3 Germany Market Size and Forecast (2018-2029)
    • 8.3.4 France Market Size and Forecast (2018-2029)
    • 8.3.5 United Kingdom Market Size and Forecast (2018-2029)
    • 8.3.6 Russia Market Size and Forecast (2018-2029)
    • 8.3.7 Italy Market Size and Forecast (2018-2029)

9 Asia-Pacific

  • 9.1 Asia-Pacific Doxorubicin Hydrochloride API Sales Quantity by Type (2018-2029)
  • 9.2 Asia-Pacific Doxorubicin Hydrochloride API Sales Quantity by Application (2018-2029)
  • 9.3 Asia-Pacific Doxorubicin Hydrochloride API Market Size by Region
    • 9.3.1 Asia-Pacific Doxorubicin Hydrochloride API Sales Quantity by Region (2018-2029)
    • 9.3.2 Asia-Pacific Doxorubicin Hydrochloride API Consumption Value by Region (2018-2029)
    • 9.3.3 China Market Size and Forecast (2018-2029)
    • 9.3.4 Japan Market Size and Forecast (2018-2029)
    • 9.3.5 Korea Market Size and Forecast (2018-2029)
    • 9.3.6 India Market Size and Forecast (2018-2029)
    • 9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
    • 9.3.8 Australia Market Size and Forecast (2018-2029)

10 South America

  • 10.1 South America Doxorubicin Hydrochloride API Sales Quantity by Type (2018-2029)
  • 10.2 South America Doxorubicin Hydrochloride API Sales Quantity by Application (2018-2029)
  • 10.3 South America Doxorubicin Hydrochloride API Market Size by Country
    • 10.3.1 South America Doxorubicin Hydrochloride API Sales Quantity by Country (2018-2029)
    • 10.3.2 South America Doxorubicin Hydrochloride API Consumption Value by Country (2018-2029)
    • 10.3.3 Brazil Market Size and Forecast (2018-2029)
    • 10.3.4 Argentina Market Size and Forecast (2018-2029)

11 Middle East & Africa

  • 11.1 Middle East & Africa Doxorubicin Hydrochloride API Sales Quantity by Type (2018-2029)
  • 11.2 Middle East & Africa Doxorubicin Hydrochloride API Sales Quantity by Application (2018-2029)
  • 11.3 Middle East & Africa Doxorubicin Hydrochloride API Market Size by Country
    • 11.3.1 Middle East & Africa Doxorubicin Hydrochloride API Sales Quantity by Country (2018-2029)
    • 11.3.2 Middle East & Africa Doxorubicin Hydrochloride API Consumption Value by Country (2018-2029)
    • 11.3.3 Turkey Market Size and Forecast (2018-2029)
    • 11.3.4 Egypt Market Size and Forecast (2018-2029)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
    • 11.3.6 South Africa Market Size and Forecast (2018-2029)

12 Market Dynamics

  • 12.1 Doxorubicin Hydrochloride API Market Drivers
  • 12.2 Doxorubicin Hydrochloride API Market Restraints
  • 12.3 Doxorubicin Hydrochloride API Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Doxorubicin Hydrochloride API and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Doxorubicin Hydrochloride API
  • 13.3 Doxorubicin Hydrochloride API Production Process
  • 13.4 Doxorubicin Hydrochloride API Industrial Chain

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Doxorubicin Hydrochloride API Typical Distributors
  • 14.3 Doxorubicin Hydrochloride API Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Doxorubicin Hydrochloride API. Industry analysis & Market Report on Doxorubicin Hydrochloride API is a syndicated market report, published as Global Doxorubicin Hydrochloride API Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029. It is complete Research Study and Industry Analysis of Doxorubicin Hydrochloride API market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,480.00
    $5,220.00
    $6,960.00
    2,742.24
    4,113.36
    5,484.48
    3,250.32
    4,875.48
    6,500.64
    547,682.40
    821,523.60
    1,095,364.80
    290,823.60
    436,235.40
    581,647.20
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report